Navigation Links
Cynosure Announces Presentation of Favorable Results from Post-Marketing Studies of Smartlipo MPX
Date:4/2/2009

doption of Smartlipo MPX and amplify the benefits of our laser lipolysis technology as a complete solution for fat removal with the potential added advantage of skin tightening and body sculpting."

Dr. DiBernardo's study, "Evaluation of Shrinkage and Skin Tightening in Laser Lipolysis vs. Liposuction: A Randomized Blinded Split Abdomen Study," will be presented as part of the ASLMS Annual Conference's ePoster session. The poster is scheduled to be available for electronic viewing in the Exhibit Hall from 9:00 a.m. to 7:00 p.m. Friday and from 9:00 a.m. to 6:30 p.m. Saturday. Dr. Katz's abstract, "A Study of the Efficacy of a 1064nm and 1320nm Sequentially Firing Nd: YAG Laser Device with an Accelerometer Safety Mechanism for Lipolysis and Skin Tightening," is scheduled to be presented at 10:54 a.m. Sunday in the Maryland ballroom.

In addition to the two studies conducted by Drs. DiBernardo and Katz, Cynosure's technology is featured in seven scientific presentations at the ASLMS Annual Conference:

  • "Efficacy of a New Fractional CO2 Laser in the Treatment of Photodamage & Acne Scarring," Bruce E. Katz, M.D., Clinical Professor, Mt. Sinai School of Medicine, Director, JUVA Skin & Laser Center, Director, Cosmetic Surgery & Laser Clinic, Mt. Sinai Medical Center, New York, New York
  • "Laser Treatment of Vascular Lesions," Pablo Boixeda, M.D., Hospital Ramon y Cajal, Madrid, Spain
  • "Smartlifting - Technological Innovation for Facial Rejuvenation," Richard Gentile, Northeastern Ohio University, Youngstown, Ohio
  • "A Nd:YAG Laser with Sequential Emission of 1320nm and 1440nm Wavelengths with CAP Technology is Effective in Neck Rejuvenation," Adriana Ribe, Natalie Ribe, Institut Natalie Ribe, Carceloa, Barcelona, Spain
  • "Evaluation of Laser Thermal Effects in Lipolysis Using a 1064/1320nm Nd:YAG Laser," Barry E. DiBe
    '/>"/>

SOURCE Cynosure, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Inc., a Johnson & Johnson (NYSE: ... surgical care, and Acclarent, Inc., a privately held ... commercializing devices that address conditions affecting the ear, ... merger agreement whereby Ethicon will acquire Acclarent in ... of estimated cash on hand at time of ...
(Date:12/16/2009)... CHICAGO, Dec. 16 A ... to manage the clinical review of specialty pharmaceuticals ... number of drugs reviewed while reducing costs. ,, ... technology company with health plan clients representing over ... WellPoint, Inc. (NYSE: WLP ), adapted ...
(Date:12/16/2009)... Inc. (NYSE: HSP ), a leading global ... it will host a conference call to discuss its ... on Thursday, Feb. 4, 2010, at 8 a.m. Central ... full-year 2009 results earlier that morning, before the U.S. ... live webcast of the conference call will be available ...
Breaking Medicine Technology:Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4Senators Feinstein and Boxer Vote to Protect Americas Kids from Tobacco 48690 1Senators Feinstein and Boxer Vote to Protect Americas Kids from Tobacco 48690 2Travis McCoy Lead Vocalist 26 Songwriter of Alternative Hip Hop Band Gym Class Heroes Travels to South Africa Philippines and India as MTV Interna 48687 1Travis McCoy Lead Vocalist 26 Songwriter of Alternative Hip Hop Band Gym Class Heroes Travels to South Africa Philippines and India as MTV Interna 48687 2Travis McCoy Lead Vocalist 26 Songwriter of Alternative Hip Hop Band Gym Class Heroes Travels to South Africa Philippines and India as MTV Interna 48687 3Travis McCoy Lead Vocalist 26 Songwriter of Alternative Hip Hop Band Gym Class Heroes Travels to South Africa Philippines and India as MTV Interna 48687 4Travis McCoy Lead Vocalist 26 Songwriter of Alternative Hip Hop Band Gym Class Heroes Travels to South Africa Philippines and India as MTV Interna 48687 5Oclaro Launches Eye Safe High Power Laser Diodes at LASER 2009 48684 1Oclaro Launches Eye Safe High Power Laser Diodes at LASER 2009 48684 2Oclaro Launches Eye Safe High Power Laser Diodes at LASER 2009 48684 3
... Critique of Industry-Funded Immune Globulin Study Uncovers ... 2007 /PRNewswire-USNewswire/ -- An analysis,released today critically ... link between autism and Rh immune globulin,(RhIg) ... thimerosal. Besides extensive design flaws, the,analysis uncovered ...
... 27, 2007 - Columbia,Laboratories, Inc. (NASDAQ: CBRX) ... pharmacokinetic study of,vaginally-administered lidocaine, which the Company ... 42-subject study was designed to provide data ... vaginal lidocaine,formulation at three dose strengths over ...
Other Medicine Technology:Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 2Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 3
(Date:12/17/2009)... 17 CareTech Solutions ( www.CareTech.com ), an ... for hospitals and health systems, was named Best in ... 2009 Top 20 Best in KLAS Awards: Software ... ranks the performance of vendors in key market segments ... ,, CareTech,s overall performance score was 90.3 ...
(Date:12/17/2009)... M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null genotypes ... The results regarding the association between GSTM1 and GSTT1 ... were contradictory. However, the majority of previous reports are ... of the GSTM1/GSTT1 null genotype with the risk of ... with larger numbers of samples. , A research ...
(Date:12/17/2009)... As the UN Climate Conference in Copenhagen approaches ... of forests in mitigating climate change. The new ... has gained widespread support as a central element ... for almost 20% of global greenhouse gas emissions, ... make a major contribution to emissions reduction. Linked ...
(Date:12/17/2009)... the aging inequity , , THURSDAY, Dec. 17 ... gender inequity: Women develop more and deeper wrinkles ... do. , The disadvantage had long been suspected, ... said Dr. Foad Nahai, a plastic surgeon practicing ... Surgery Journal . The study appears in the ...
(Date:12/17/2009)... - Procedure Provides Efficient Mechanism to Pursue ... QC, Dec. 17 /PRNewswire-FirstCall/ - Labopharm Inc. ... announced it has initiated the regulatory approval ... Europe under the Decentralized Procedure (DCP). The ... a company to simultaneously pursue regulatory approval ...
Breaking Medicine News(10 mins):Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 2Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 3Health News:Forests take center stage at Copenhagen 2Health News:Mouth Area Wrinkles More in Women Than Men 2Health News:Mouth Area Wrinkles More in Women Than Men 3Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 2Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 3
... May 14 Quark Pharmaceuticals, Inc., a development-stage ... (RNAi)-based therapeutics, today announced that Elena Feinstein, M.D., ... "siRNA Therapeutics for Prevention of Ocular and Inner ... Nucleic Acid Diagnostics & Therapeutics. The event was ...
... for Consumers KANSAS CITY, Mo., May 14 ... 8.5 percent,(1) families are living on tighter budgets, and ... Despite these challenges, there are still ways for consumers ... to the National Association of Insurance Commissioners (NAIC). "These ...
... Corporation (Pink Sheets: CGCP) the "Company", a leading developer ... suffering from severe angina, today reported financial results for ... Financial ResultsNet revenues in the first quarter of 2009 ... first quarter net revenues of $2,982,000. During the ...
... New Research on Antioxidant-Enhanced SuncareKENILWORTH, N.J., May 14 ... SGP ), introduces COPPERTONE (R) , ... a new line of sunscreens enriched with antioxidants ... harmful free radicals created by UV exposure. ...
... convenience and broader access to an effective treatment ... frequent heartburn - Once-daily, prescription-strength Prevacid(R) 24HR is ... the treatment of frequent heartburn in the US ... heartburn for a full 24 hours BASEL, Switzerland, ...
... Significantly Impacted After Breaking a BoneSpecial Council of ... to Make Bone Health a Priority Before They ... Know My Bones Council today announced results ... that one-out-of-five women with postmenopausal osteoporosis (PMO) are ...
Other Medicine News:Health News:Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and Inner Ear Sensory Cell Damage 2Health News:Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and Inner Ear Sensory Cell Damage 3Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 2Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 3Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 4Health News:Health Insurance: Stay Protected Amid Layoffs, Budget Cuts 5Health News:Cardiogenesis Reports First Quarter 2009 Results 2Health News:Cardiogenesis Reports First Quarter 2009 Results 3Health News:Cardiogenesis Reports First Quarter 2009 Results 4Health News:Cardiogenesis Reports First Quarter 2009 Results 5Health News:Cardiogenesis Reports First Quarter 2009 Results 6Health News:Introducing COPPERTONE(R) NutraShield(R) With Dual Defense(R), New Sunscreen Line With Antioxidants To Help Promote Natural Skin Repair 2Health News:Introducing COPPERTONE(R) NutraShield(R) With Dual Defense(R), New Sunscreen Line With Antioxidants To Help Promote Natural Skin Repair 3Health News:Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation 2Health News:Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation 3Health News:Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation 4Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 2Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 3Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 4Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 5Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 6Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 7Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 8Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 9
... Tecans MiniPrep series of robotic workstations ... The MiniPrep is the ideal automation ... automation of routine laboratory procedures, improving throughput, ... based Gemini for MiniPrep software allows you ...
... QFill2 is the ideal system for fast, accurate ... pressure driven, pinch valve controlled dispensing mechanism, ensures ... all of the components that come into contact ... clean, and autoclave. The unique compact design saves ...
... Automatic dispenser for low volumes. Dispenses ... 1536 -well format. Fast throughput of less ... productivity. The dispenser features an intuitive user ... be used to dispense liquids and suspensions, ...
... low volumes. Dispenses volumes down to 0.5ul ... throughput of less than 30 seconds per ... an intuitive user interface that provides one-button ... liquids and suspensions, beads, or cells, with ...
Medicine Products: